<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0019251"><a href="http://purl.obolibrary.org/obo/MONDO_0019251">MONDO:0019251</a></h3>
<p><strong>Label:</strong> Oligosaccharidosis</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0009738">MONDO:0009738</a> (glycoproteinosis), <a href="http://purl.obolibrary.org/obo/MONDO_0017734">MONDO:0017734</a> (sialidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0009561">MONDO:0009561</a> (alpha-mannosidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0012221">MONDO:0012221</a> (alpha-N-acetylgalactosaminidase deficiency type 1), <a href="http://purl.obolibrary.org/obo/MONDO_0017779">MONDO:0017779</a> (alpha-N-acetylgalactosaminidase deficiency),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_309294">Orphanet:309294</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79281">Orphanet:79281</a>, <a href="http://www.orpha.net/ORDO/Orphanet_812">Orphanet:812</a>, <a href="http://www.orpha.net/ORDO/Orphanet_87876">Orphanet:87876</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256150">OMIM:256150</a>, <a href="http://www.orpha.net/ORDO/Orphanet_61">Orphanet:61</a>, <a href="http://purl.obolibrary.org/obo/OMIM_248500">OMIM:248500</a>, <a href="http://purl.obolibrary.org/obo/OMIM_256550">OMIM:256550</a>, <a href="http://www.orpha.net/ORDO/Orphanet_3137">Orphanet:3137</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609241">OMIM:609241</a>, <a href="http://www.orpha.net/ORDO/Orphanet_79279">Orphanet:79279</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609242">OMIM:609242</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0012067">HP:0012067</a> (Glycopeptiduria) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003461">HP:0003461</a> (Increased urinary O-linked sialopeptides) 66.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0030680">HP:0030680</a> (Abnormality of cardiovascular system morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0025031">HP:0025031</a> (Abnormality of the digestive system) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0012547">HP:0012547</a> (Abnormal involuntary eye movements) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0011804">HP:0011804</a> (Abnormality of muscle physiology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0011442">HP:0011442</a> (Abnormality of central motor function) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0011389">HP:0011389</a> (Functional abnormality of the inner ear) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0011283">HP:0011283</a> (Abnormality of the metencephalon) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) and <a href="http://purl.obolibrary.org/obo/HP_0011282">HP:0011282</a> (Abnormality of hindbrain morphology) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004305">HP:0004305</a> (Involuntary movements) and <a href="http://purl.obolibrary.org/obo/HP_0010471">HP:0010471</a> (Oligosacchariduria) 62.50%</li>
</ul>
</body>
</html>
